Stay updated on KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Sign up to get notified when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.

Latest updates to the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0 as part of a site update.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision update from v3.4.1 to v3.4.2 was applied. The page content and functionality appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No visible content or functionality changes were detected.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This appears to be a backend version update with no changes to study details or user-facing information.SummaryDifference0.0%

- Check102 days agoChange DetectedAdded a Locations section listing trial sites by state (Arizona, California, Connecticut, District of Columbia, Florida, Illinois, Louisiana, Maryland, Massachusetts, Minnesota, New York, Pennsylvania, South Carolina, Washington, Wisconsin) and updated the revision to v3.3.3.SummaryDifference1%

Stay in the know with updates to KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.